APVO vs BILL · $9.9M cap vs rev $1.65B
Aptevo Therapeutics Inc (APVO) versus Bill Com Holdings Inc (BILL) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
APVO does not have a complete income-statement cache yet.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
APVO currently screens at market cap $9.9M. BILL currently screens at market cap $4.78B.
Not investment advice. Open the APVO and BILL stock pages for the full models.
Not investment advice.